Literature DB >> 1871797

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease.

L D Sharples1, N Caine, P Mullins, J P Scott, E Solis, T A English, S R Large, P M Schofield, J Wallwork.   

Abstract

This study demonstrates the importance of analyzing survival by cause of death in order to achieve a better understanding of the prognostic indicators involved. It further emphasizes the need for analysis of risk factors in both univariate and multivariate models, and the danger of making judgements based on premature analysis of data on follow-up after heart transplantation. Survival following transplantation is characterized by the major hazards of early death due to infection and rejection and late graft loss due to coronary occlusive disease (COD). This study summarizes the first-graft survival experience for 323 transplant patients at Papworth Hospital, and assesses a number of potential risk factors for (1) early mortality, (2) late mortality from COD, and (3) development of COD. The potential risk factors considered for all hazards are donor and recipient age, sex, blood group, and matching of these factors; donor cause of death and recipient immunosuppression; inotropic support; waiting time; preoperative diagnosis and previous cardiac surgery; ischemic time; and extubation time. In addition, for development of, and graft loss from, COD, perioperative rejection and cytomegalovirus infection; hypertension at discharge; and cholesterol, triglycerides, and lipids at two years were assessed as risk factors. Advances in immunosuppression were observed to have increased overall survival rates and decreased mortality from infection, rejection, and COD, as well as decreasing morbidity from COD. Fatal rejection was found to be more likely in female recipients, recipients over 40 years, recipients of grafts from donors over 30 years old, patients who were transplanted for valvular heart disease, and patients who waited less than three months for their transplant. Male recipients of female donor organs were more likely to lose their grafts as a result of COD. Patients older than 50 and hearts from donors older than 40 conferred a high risk of development of and loss from COD. Patients transplanted for ischemic heart disease were more likely to develop COD. High cholesterol, low HDL, high LDL, and high triglycerides at two years after transplant showed some evidence of high risk for the subsequent development of COD, although these relationships are not statistically significant at this stage. Contrary to other recent studies, cytomegalovirus infection was not found to be a risk factor for the development of COD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871797     DOI: 10.1097/00007890-199108000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Mortality, rehospitalization, and post-transplant complications in gender-mismatched heart transplant recipients.

Authors:  Anne Jalowiec; Kathleen L Grady; Connie White-Williams
Journal:  Heart Lung       Date:  2017-05-10       Impact factor: 2.210

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels.

Authors:  A Gamba; F Mamprin; R Fiocchi; M Senni; G Troise; P Ferrazzi; R Ferrara; G Corbetta
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

5.  Simvastatin after orthotopic heart transplantation. Costs and consequences.

Authors:  K J Krobot; K Wenke; B Reichart
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

6.  Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.

Authors:  M E Russell; D H Adams; L R Wyner; Y Yamashita; N J Halnon; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Coronary occlusive disease and late graft failure after cardiac transplantation.

Authors:  P A Mullins; N R Cary; L Sharples; J Scott; D Aravot; S R Large; J Wallwork; P M Schofield
Journal:  Br Heart J       Date:  1992-09

9.  When and why do heart transplant recipients die? A 7 year experience of 1068 cardiac transplants.

Authors:  P Gallo; G Baroldi; G Thiene; L Agozzino; E Arbustini; G Bartoloni; E Bonacina; C Bosman; G Catani; P Cocco
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.